Epistructure-Based Design of Drugs with Controlled Promiscuity

about

Epistructure-Based Design of Drugs with Controlled Promiscuity

Item

http://www.wikidata.org/entity/Q56969981

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2016

@uk

name

Epistructure-Based Design of Drugs with Controlled Promiscuity

@en

Epistructure-Based Design of Drugs with Controlled Promiscuity

@nl

type

Item

label

Epistructure-Based Design of Drugs with Controlled Promiscuity

@en

Epistructure-Based Design of Drugs with Controlled Promiscuity

@nl

prefLabel

Epistructure-Based Design of Drugs with Controlled Promiscuity

@en

Epistructure-Based Design of Drugs with Controlled Promiscuity

@nl

P1476

Epistructure-Based Design of Drugs with Controlled Promiscuity

@en

P2093

Ariel Fernández

http://www.w3.org/2001/XMLSchema#string

P2860

Structural reengineering of imatinib to decrease cardiac risk in cancer therapy

Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

Cardiac dysfunction in the trastuzumab clinical trials experience

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

A quantitative analysis of kinase inhibitor selectivity

Cancer genes and the pathways they control

Drug discovery: playing dirty

Can we rationally design promiscuous drugs?

A small molecule-kinase interaction map for clinical kinase inhibitors

P304

351-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-30852-4_13

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime